Forte Biosciences
FBRX • NASDAQ • Stock Fundamentals
Forte Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul A. Wagner, with a market cap of $449.3M.
Market Cap$449.3M
Employees11.0
CEOPaul A. Wagner
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
FBR
Forte Biosciences FAQ
Common questions about Forte Biosciences
Forte Biosciences (FBRX) has a market capitalization of $449.3M and trades on NASDAQ.
Forte Biosciences has approximately 11 employees.